Triglyceride glucose index and atherogenic index of plasma predict rapid kidney function decline in cardiovascular–kidney–metabolic syndrome: the first longitudinal evidence from CHARLS

Our findings demonstrate the utility of the TyG index and AIP as effective biomarkers for stratifying the risk of RKFD in the clinical management of CKM syndrome. Furthermore, uric acid plays a significant partial mediating role in this relationship.